Hologic Liabilities And Stockholders Equity from 2010 to 2025

HOLX Stock  USD 65.45  7.35  10.10%   
Hologic Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity is likely to outpace its year average in 2025. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Hologic's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
1989-09-30
Previous Quarter
8.9 B
Current Value
9.2 B
Quarterly Volatility
3.9 B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Hologic over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Hologic's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Hologic Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean8,110,887,562
Geometric Mean5,398,411,985
Coefficient Of Variation31.05
Mean Deviation1,595,789,117
Median8,919,900,000
Standard Deviation2,518,383,684
Sample Variance6342256.4T
Range11.1B
R-Value0.53
Mean Square Error4908909.8T
R-Squared0.28
Significance0.04
Slope278,700,284
Total Sum of Squares95133845.7T

Hologic Liabilities And Stockholders Equity History

202511.1 B
202410.5 B
20239.2 B
20229.1 B
20219.1 B
20208.9 B
20197.2 B

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity10.5 B11.1 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.